Mobile site of the medical newspaper, Binex Year 15 Pharmaceutical companies · 18 articles ‘Temporary suspension of salary’

[의학신문·일간보사=이승덕 기자]After Binex, 18 items from 15 drug companies were temporarily suspended.

These are items that are covered by salary among the 32 items ordered and manufactured in the same way as Binex.

On the 9th, the Ministry of Health and Social Welfare announced such measures through the ‘information on the suspension of insurance drug benefits.

On the 8th, Binex manufactured synthetic drugs in a different way than that reported on the 8th, and received measures from the Ministry of Food and Pharmaceutical Safety and the Ministry of Social Welfare to suspend the manufacture and sale, respectively.

This measure is also a follow-up measure after the temporary suspension of manufacture and sale by the Ministry of Food and Drug Safety and decided to discontinue its use.

Consequently, the Ministry of Health and Social Welfare has temporarily suspended and oriented drug payments for 18 drugs that are covered by the medical insurance benefits of medical treatment on March 9.

Regarding the 18 covered drugs, there are four dexibropene-based products, such as △ Dicarol tablet (Ildong Pharmaceutical), △ Exifen tablet (Hanall Biopharma), △ Sonyfen 300 mg tablet (JW’s new drug) △ tablet of Deckfen (Alarm Pharmaceutical).

Fluoxetine Hydrochloride Component Products include Un Unizak 10mg Capsule (Unimed Pharmaceuticals) △ Unizak 20mg Capsule (Unimed Pharmaceuticals) △ Slicetin 10mg Capsule (Dongkuk Pharmaceutical) △ Slicetin Capsule (Dongkuk Pharmaceutical) △ Wellfit 10mg Capsule (WooriDul Pharmaceutical)) and the component of Fluoxetine Hydrochloride is Caps Wellfit Capsule (Woorideul Pharmaceutical).

The glimepiride component products are △ Gril tablet (SPC) Glu Gluvi tablet (Alvogen Korea), and the ciprofloxacin hydrochloride product is △ Punglim ciprofloxacin hydrochloride hydrochloride hydrate (Pungrim Muek) △ Nuroxacin tablet (Pharmaceutical Guju) △ Siloxin Pharmaceutical Tablet 250mg) △ Ciflon Tablet 250mg (Hana Pharmaceutical), △ Siroctan Tablet 250mg (I-Cure) △ Cifloc Q Tablet 250mg (Cho-A Pharmaceutical).

The Ministry of Health and Social Welfare also took steps to allow a claim for medical treatment on March 9, which inevitably occurred by prescription and dispensing before the notice of suspension of payment.